91 件中 21 - 40 件目
英語 ：Takahara M, Nagato T, Nozaki Y, Kumai T, Katada A, Hayashi T, Harabuchi Y. , A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy. , Cellular Immunology, 341 （103925 - ） , 2019 , （IF:3.291）
英語 ：Hirata-Nozaki Y, Ohkuri T, Ohara K, Kumai T, Nagata M, Harabuchi S, Kosaka A, Nagato T, Ishibashi K, Oikawa K, Aoki N, Ohara M, Harabuchi Y, Uno Y, Takei H, Celis E, Kobayashi H. , PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma. , Journal of Translational Medicine, 17 (1) （207 - ） , 2019 , （IF:4.098）
英語 ：Nagato T, Ueda S, Takahara M, Kishibe K, Komabayashi Y, Kumai T, Ohara K, Hirata-Nozaki Y, Harabuchi S, Hayashi R, Ohkuri T, Bernasconi M, Nadal D, Kobayashi H, Harabuchi Y. , Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma. , Laboratory Investigation, 99 (5) （612 - 624） , 2019 , （IF:4.254）
英語 ：Nagato T, Kishibe K, Harabuchi Y. , Subglottic stenosis in granulomatosis with polyangiitis. , The American Journal of the Medical Sciences, 357 (4) （e13 - e14） , 2019 , （IF:1.773）
英語 ：Sultan H, Kumai T, Nagato T, Wu J, Salazar AM, Celis E. , The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice. , Cancer Immunology, Immunotherapy, 68 (3) （455 - 466） , 2019 , （IF:4.225）
英語 ：Ohara K, Ohkuri T, Kumai T, Nagato T, Nozaki Y, Ishibashi K, Kosaka A, Nagata M, Harabuchi S, Ohara M, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H. , Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma. , OncoImmunology, 7 (9) （e1466771 - ） , 2018 , （IF:5.503）
英語 ：Takahara M, Hirata Y, Nagato T, Kishibe K, Katada A, Hayashi T, Kishibe M, Ishida-Yamamoto A, Harabuchi Y. , Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: A retrospective subjective and objective quantitative analysis of 138 patients. , The Journal of Dermatology, 45 (7) （812 - 823） , 2018 , （IF:2.788）
英語 ：Komabayashi Y, Kishibe K, Nagato T, Ueda S, Takahara M, Harabuchi Y. , Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma. , Hematological Oncology, 35 (4) （655 - 663） , 2017 , （IF:3.494）
英語 ：Uehara J, Ohkuri T, Kosaka A, Ishibashi K, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Ishida-Yamamoto A, Kobayashi H. , Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb. , Biochemical and Biophysical Research Communications, 490 (2) （521 - 527） , 2017 , （IF:2.466）
英語 ：Nagato T, Ohkuri T, Ohara K, Hirata Y, Kishibe K, Komabayashi Y, Ueda S, Takahara M, Kumai T, Ishibashi K, Kosaka A, Aoki N, Oikawa K, Uno Y, Akiyama N, Sado M, Takei H, Celis E, Harabuchi Y, Kobayashi H. , Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy. , Cancer Immunology, Immunotherapy, 66 (7) （877 - 890） , 2017 , （IF:4.846）
英語 ：Ohkuri T, Kosaka A, Ishibashi K, Kumai T, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H. , Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site. , Cancer Immunology, Immunotherapy, 66 (6) （705 - 716） , 2017 , （IF:4.846）
英語 ：Otaka R, Takahara M, Ueda S, Nagato T, Kishibe K, Nomura K, Katada A, Hayashi T, Harabuchi Y. , Up-regulation of CX3CR1 on tonsillar CD8-positive cells in patients with IgA nephropathy. , Human Immunology, 78 (4) （375 - 383） , 2017 , （IF:2.127）
英語 ：Ishibashi K, Kumai T, Ohkuri T, Kosaka A, Nagato T, Hirata Y, Ohara K, Oikawa K, Aoki N, Akiyama N, Sado M, Kitada M, Harabuchi Y, Celis E, Kobayashi H. , Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy. , Oncoimmunology, 30 (5) （e1169356 - ） , 2016 , （IF:6.266）
英語 ：Takahara M, Nagato T, Kishibe K, Ueda S, Komabayashi Y, Yamashina M, Takahashi K, Harabuchi Y. , Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy. , Hematological Oncology （Epub ahead of print - ） , 2015 , （IF:3.084）
英語 ：Kumai T, Ohkuri T, Nagato T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Celis E, Harabuchi Y, Kobayashi H. , Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma. , Scientific Reports, 5 (5) （16280 - ） , 2015 , （IF:5.578）
英語 ：Kumai T, Nagato T, Kobayashi H, Komabayashi Y, Ueda S, Kishibe K, Ohkuri T, Takahara M, Celis E, Harabuchi Y. , CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma. , Cancer Immunology, Immunotherapy, 64 (6) （697 - 705） , 2015 , （IF:3.943）
英語 ：Nagato T, Lee YR, Harabuchi Y, Celis E. , Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumors. , Clinical Cancer Research, 20 (5) （1223 - 1234） , 2014 , （IF:7.837）
英語 ：Komabayashi Y, Kishibe K, Nagato T, Ueda S, Takahara M, Harabuchi Y. , Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma. , American Journal of Hematology, 89 (1) （25 - 33） , 2014 , （IF:4.138）
英語 ：Takahara M, Nagato T, Komabayashi Y, Yoshino K, Ueda S, Kishibe K, Harabuchi Y. , Soluble ICAM-1 secretion and its functional role as an autocrine growth factor in nasal NK/T cell lymphoma cells. , Experimental Hematology, 41 (8) （711 - 718） , 2013 , （IF:2.907）
英語 ：Yoshino K, Kishibe K, Nagato T, Ueda S, Komabayashi Y, Takahara M, Harabuchi Y. , Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27. , British Journal of Haematology, 160 (3) （331 - 342） , 2013 , （IF:4.942）
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.